Table of Contents : Transplantation Direct

Journal Logo

Table of Contents

Table of Contents

Author Information
doi: 10.1097/01.TDX.0000753180.46113.1b
  • Open

Abstracts for the 2021 Transplantation Society of Australia and New Zealand Annual Scientific Meeting

IRI and non T cell Immunobiology

S1 EXTENDING THE LIMITS OF HUMAN LIVER PRESERVATION: INITIAL PRE-CLINICAL EXPERIENCES WITH A CUSTOMISED MODEL FOR PROLONGED NORMOTHERMIC MACHINE PERFUSION.

S1 MOLECULAR ALTERATIONS IN DCD RAT HEARTS AFTER ASYSTOLIC WARM ISCHEMIA AND NORMOTHERMIC EX VIVO REPERFUSION

S2 ADOPTIVE TOLEROGENIC DENDRITIC CELL THERAPY PROTECTS AGAINST RENAL ISCHEMIA REPERFUSION INJURY

S3 The use of insulating jackets in renal transplantation

S3 Treatment with the spider venom peptide Hi1a is protective in a mouse model of renal ischemia reperfusion injury.

S4 DONOR INTERLEUKIN-6 GENOTYPE INFLUENCES THE DEVELOPMENT OF GRAFT-VERSUS-HOST-DISEASE IN A HUMANISED MOUSE MODEL

S4 INVESTIGATING A ROLE FOR DONOR-DERIVED LYMPHOCYTES IN OUTCOMES FOLLOWING LUNG TRANSPLANTATION.

S5 EXPLORING GENOMIC DATA REVEALS A CONSERVED TRANSCRIPTOME IN TOLEROGENIC DENDRITIC CELLS.

S5 TH1 AND TH2 CYTOKINES RECIPROCALLY MODULATE B CELL REGULATORY FUNCTIONS

S6 TACROLIMUS INHIBITS MITOGEN AND MIXED LYMPHOCYTE REACTION INDUCED PIG T-CELL PROLIFERATION IN VITRO

T Cell Biology

S6 PD-L1/PD-1 INTERACTIONS ARE CRITICAL FOR TOLERANCE INDUCTION IN PRIMED SKIN GRAFT RECIPIENTS FOLLOWING LIVER-DIRECTED MHC CLASS I GENE TRANSFER

S7 DETERMINING THE TCR REPERTOIRE IN DIRECT PMHC ALLORECOGNITION BY CD8+ T CELLS

S8 PURINERGIC SIGNALLING IN A HUMANISED MOUSE MODEL OF GRAFT-VERSUS-HOST DISEASE (GVHD)

S8 DONOR LYMPHOCYTES ARE RETAINED IN TISSUE MISMATCH BUT NOT MHC MISMATCH TRANSPLANTATION

S9 IDENTIFICATION OF A NOVEL SUBSET OF XENO-ANTIGEN SPECIFIC MEMORY CD4+FOXP3+TREGS IN ISLET-XENOTRANSPLANT TOLERANCE

S9 COMPARISON OF IN VITRO SUPPRESSION OF CD4+CD25-T EFFECTOR CELL PROLIFERATION BY TH2-LIKE TREG AND NAÏVE TREG USING A REFINED FLOW CYTOMETRY BASED ASSAY

S10 THE DEVELOPMENT OF GAD65-CAR TREGS AS A METHOD OF IMMUNOSUPPRESSION FOR ISLET TRANSPLANT RECIPIENTS

S10 PHOSPHOLIPASE A2 RECEPTOR CAR T CELLS LOCALISE TO THE KIDNEY

S11 IN VITRO ACTIVATION OF HUMAN CD4+CD25+CD127LO TREG SUBPOPULATIONS

Basic Science; Other

S11 INNATE IMMUNE SENSING AND TISSUE REMODELLING OF A BIODEGRADABLE TEMPERING MATRIX SUPPORTED ISLET GRAFT

S12 COMBINATIONAL THERAPY WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE AND THE P2X7 ANTAGONIST BRILLIANT BLUE-G REDUCES LIVER DISEASE IN A HUMANISED MOUSE MODEL OF GRAFT-VERSUS-HOST DISEASE

S12 POST-TRANSPLANT CYCLOPHOSPHAMIDE REDUCES BLASTING T CELLS IN HUMANISED MICE WITH SUBCLINICAL GRAFT-VERSUS-HOST DISEASE

S13 INTRACUTANEOUS BIODEGRADEABLE TEMPORIZING MATRIX (BTM) AS AN ALTERNATIVE SITE FOR ISLET TRANSPLANTATION

S13 UNDER-UTILISATION OF SODIUM-GLUCOSE COTRANSPORTERS-2 INHIBITORS (SGLT2i) AND GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS (GLP1RA) IN KIDNEY TRANSPLANT RECIPIENTS (KTR) WITH TYPE 2 DIABETES MELLITUS (T2DM)

S14 SELECTION OF A NOVEL AAV2/TNFAIP3 VECTOR FOR LOCAL SUPPRESSION OF ISLET XENOGRAFT INFLAMMATION

Outcomes and Complications

S15 ASSESSMENT OF DQ RISK EPITOPE MISMATCH AFTER LUNG TRANSPLANTATION AS A PREDICTOR OF CHRONIC LUNG ALLOGRAFT DYSFUNCTION

S15 AUSTRALIAN EXPERIENCE WITH TOTAL PANCREATECTOMY WITH AUTO ISLET CELL TRANSPLANT (TP-IAT) TO TREAT CHRONIC PANCREATITIS

S16 Characterisation of chronic lung allograft dysfunction by airway oscillometry in post-lung transplantation: a multi-centre cross-sectional study

S16 MATERNAL CHARACTERISTICS AND BIRTH OUTCOMES FOR MOTHERS AFTER KIDNEY TRANSPLANTATION: AN ANALYSIS OF LINKED ANZDATA REGISTRY AND PERINATAL DATASETS OVER 22 YEARS

S18 DEFINING DONOR IN SITU ISCHAEMIC TIME (DISIT) AND ITS IMPACT ON KIDNEY ALLOGRAFT FUNCTION

S18 PATIENT DYNAMICS ACROSS A LIFESPAN OF KIDNEY WAITLISTING AND TRANSPLANTATION: AN AUSTRALIAN COHORT STUDY

S19 ARTERIAL RECONSTRUCTION IN SPLIT LIVER TRANSPLANTATION USING INTERPOSITION GRAFTS IS SAFE AND EFFECTIVE

S19 THE EFFECT OF SURGICAL CLOSURE OF HEMODIALYSIS ARTERIOVENOUS FISTULA AFTER SUCCESSFUL KIDNEY TRANSPLANTATION

S20 EARLY VERSUS LATE RENAL ACUTE ANTIBODY MEDIATED REJECTION: A COMPARISON OF TREATMENT APPROACHES AND OUTCOMES IN AUSTRALIA AND NEW ZEALAND

S21 GRAFT SURVIVAL AND VISUAL ACUITY FOLLOWING SURGICAL VARIATIONS OF CORNEAL TRANSPLANTATION IN EYES WITH FUCHS ENDOTHELIAL DYSTROPHY

S21 PREDICTING KIDNEY TRANSPLANTATION OUTCOMES; IS DONOR TERMINAL, ADMISSION OR HIGHEST ESTIMATED GLOMERULAR FILTRATION RATE BEST?

S22 NOTIFIABLE INFECTIONS AMONG ORGAN TRANSPLANT RECIPIENTS: AN AUSTRALIAN DATA-LINKED COHORT STUDY, 2000-2015

S22 INCIDENCE AND MORTALITY RELATED TO CANCER IN KIDNEY TRANSPLANT RECIPIENTS: GEOGRAPHICAL VARIATION AND CENTRE-SPECIFIC IMMUNOSUPPRESSIVE MANAGEMENT

S23 EVALUATING NEUTROPHILS AS A BIOMARKER FOR DELAYED GRAFT FUNCTION IN KIDNEY TRANSPLANT RECIPIENTS

S23 Outcomes of steroid-free immunosuppression and therapeutic anti-coagulation in pancreas transplantation - the Adelaide experience of an initial 10 patient cohort

S24 RELATIVE SURVIVAL IN KIDNEY TRANSPLANT RECIPIENTS WITH DE-NOVO CANCERS VS NON-TRANSPLANT CANCER PATIENTS: A POPULATION STUDY 1980-2016

S24 Factors Influencing cell-free DNA levels: Implications for donor derived cell-free DNA Assessment in Transplant Patients

S25 To drain or not to Drain – that is the question? A Review of role of retroperitoneal drains following Kidney transplantation

S25 Case Study: Impact of COVID-19 on cell free DNA levels in Kidney Transplant Patients

S26 OPTIMAL SURGICAL MANAGEMENT OF RENAL HYPERPARATHYROIDISM

S26 Splenic Artery Aneurysm management in the cirrhotic patient listed for Liver Transplantation: A systematic review

S27 OUTCOMES OF KIDNEY TRANSPLANTATION FROM ECMO-SUPPORTED DONORS: A SYSTEMATIC REVIEW

S27 Treatment of Sapovirus Infection in a Renal Transplant Patient

S28 RENAL ALLOGRAFT TORSION AND PSEUDOANEURYSMS OF THE PANCREATIC ARTERY FOLLOWING SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION: A CASE REPORT

S28 A 25-year experience with two-in-one and en bloc kidney transplants

S29 EVALUATION OF GRAFT FUNCTION AFTER KIDNEY RE-TRANSPLANTATION IN A SINGLE CENTRE IN VIETNAM

S29 Renal Allograft Compartment Syndrome: Incidence and Technique for Avoidance

S30 dual kidney transplantation outcomes – is it worth the risk?

S30 SERUM SICKNESS FOLLOWING ANTI-THYMOCYTE GLOBULIN TREATMENT FOR ALLOGRAFT REJECTION. A REPORT OF TWO CASES WITH PRIOR EXPOSURE TO RABBITS.

Donation and Allocation

S31 HEALTH SERVICE UTILISATION AFTER ORGAN DONATION AMONG LIVING DONORS IN NSW, AUSTRALIA: THE SAFE-BOD DATA LINKAGE STUDY

S31 The impact of Victorian Key Performance Indicators (KPIs) on wait listing for kidney transplantation for Indigenous and non-Indigenous patients starting dialysis.

S32 Cancer transmissions and non-transmissions from solid organ transplantation: A NSW cohort study

S32 Verification of suspected melanomas in deceased organ donor referrals: a population-based cohort study using data-linkage, 2010-2015

S33 Impact of the HLA-based matching system on clinical outcomes and racial disparity in Australia’s Deceased Donor Kidney Transplantation Program

S33 Increasing the donor pool: Heart transplantation with Hepatitis C positive donors to Hepatitis C naïve recipients- the first Australian experiences.

S34 THE AUSTRALIAN AND NEW ZEALAND LIVING KIDNEY DONOR PROFILE INDEX

S34 LONG-TERM METABOLIC COMPLICATIONS FOLLOWING SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION: A SINGLE-CENTRE RETROSPECTIVE STUDY

S35 Development of a donor-recipient matching algorithm for lung transplantation in NSW

S35 THE USE OF BURNS VICTIMS AS A SOURCE OF DECEASE ORGAN DONATION

S36 A REVIEW OF STAKEHOLDER PREFERENCES FOR INVOLVEMENT IN TRANSPLANT OFFERS

S36 UNDERSTANDING AND ATTITUDES TOWARD ACCEPTING AN INCREASED VIRAL RISK DONOR IN PATIENTS ACTIVE ON THE KIDNEY TRANSPLANT WAITING LIST

Clinical; Other

S37 IMPLEMENTATION OF INCREASED VIRAL RISK DONOR WAITING LIST FOR PRE-CONSENTED WAITLISTED KIDNEY TRANSPLANT RECIPIENTS IN VICTORIA: TWO-YEAR DATA

S37 Gene expression analysis identifies potential links between cytomegalovirus infection and chronic rejection following lung transplantation

S38 Dual Kidney Transplantation: Two good or double trouble?

S38 The Epidemiology of Hereditary Pancreatitis in South Australia

S40 Paediatric kidney transplants from donors aged 1 year and under: an analysis of the Australian and New Zealand Dialysis and Transplant Registry (ANZDATA) from 1963 to 2018

S41 Microsampling methods for simultaneous estimation of tacrolimus, mycophenolic acid and prednisolone concentrations in adult kidney transplant recipients

S41 How to repair a donor renal vein injury with Inferior Vena Cava patch

S42 Trends in Nephrology research and authorship: the death of basic science research in Nephrology within Australia and New Zealand

S42 WHY ARE WE NOT LISTING ABORIGINAL AND TORRES STRAIT ISLANDER PEOPLE FOR KIDNEY TRANSPLANTS?

S43 T-follicular-helper and B memory cells in antibody-mediated rejection after kidney transplantation.

S43 The impact of Chronic Pancreatitis on the Paediatric Population of South Australia

S44 RENAL TRANSPLANT SCREENING FOR ADVANCED COLORECTAL NEOPLASIA IN THE WELLNESS CLINIC

S44 On the Hunt: Hunting Transplant Project – Purple House Panuku Mentor Team

S45 COMPARISON OF PANCREATA AND ISLET PREPARATIONS FROM HUMAN ORGAN DONORS - Influence of family history of diabetes or marginal levels of HbA1C.

S45 SEQUENTIAL MULTI-ORGAN TRANSPLANTATION FOR DYSKERATOSIS CONGENITA

S46 Bridging the cultural gap: improving Indigenous Australian kidney transplant access

S46 “On Track to Transplant” – A Patient Navigator Model

S47 Specific human leukocyte antigen eplet mismatches and acute rejection in simultaneous pancreas-kidney transplant recipients

S47 First reported case of successful deceased donor kidney transplantation in THE pRESENCE OF cold agglutinins and triple positive anti-phospholipid antibodies

S48 FATE OF ABSTRACTS PRESENTED AT THE TRANSPLANTATION SOCIETY OF AUSTRALIA and NEW ZEALAND ANNUAL SCIENTIFIC MEETINGS.

S48 RANGE AND CONSISTENCY OF INFECTION OUTCOMES REPORTED IN TRIALS CONDUCTED IN KIDNEY TRANSPLANT RECIPIENTS: A SYSTEMATIC REVIEW

S49 Effect of pre-transplant splenectomy vaccinations on anti-A/B antibody titres in ABO-incompatible renal transplant recipients

S49 FINGERPRICK SAMPLING WITH HEMAPEN® TO MONITOR TACROLIMUS CONCENTRATIONS

S50 “Hyperacute” T Cell Mediated Rejection (TCMR) of a stable renal allograft following PD1 blockade for recurrent Head and Neck Squamous Cell Carcinoma (HNSCC)

Transplantation Surgery

S50 Normothermic EX vivo machine perfusion prior to Transplantation of the Kidney (NEXT-Kidney)

S51 Prospective evaluation of a closed incision negative pressure wound therapy system on surgical site infections and wound complications in kidney transplant recipients.

S51 Incidental renal lesions found during cadaveric donor surgery and subsequent use in renal transplantation after ex-vivo tumourectomisation

S52 Developing a novel porcine autotransplantation model of robotic-assisted heterotopic kidney transplantation

Copyright © 2021 The Transplantation Society of Australia and New Zealand. Transplantation Direct. Published by Wolters Kluwer Health, Inc.